A Novel Disease with Deficiency of Mitochondrial Very-Long-Chain Acyl-CoA Dehydrogenase
Toshifumi Aoyama(Shinshu University), T. Hashimoto(Ōtani University), Yasushi Uchida(Shinshu University), William J. Rhead(Children's Hospital of Wisconsin), Karen Hofman(South African Medical Research Council), Michael Marble(Shinshu University), Richard I. Kelley(Kennedy Krieger Institute), James H. Tonsgard(Shinshu University)
Cited by 152
Related Papers
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|843
Defining and conceptualising the commercial determinants of health
|The Lancet|2023|644
Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders
|New England Journal of Medicine|2007|357
X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria
|The Journal of Pediatrics|1991|275
Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation
|Proceedings of the National Academy of Sciences|1998|254